Renée J. Gentry, Esq. is one of the leading experts on vaccine injury litigation in the National Vaccine Injury Compensation Program (NVICP) with nearly 20 years of experience in all phases of cases from entitlement to damages and appeals. She has chaired numerous conferences on Vaccine Injury Litigation and has been a featured speaker regarding the NVICP at Judicial Conferences, Vaccine Injury Litigation Boot Camps for New Practitioners and a Court of Federal Claims Brown Bag Series on the use of experts in the NVICP.
Ms. Gentry has advised numerous congressional members, staff, and committees on issues relevant to the NVICP, and she has also helped to draft and introduce critical legislation to improve the NVICP. She is licensed to practice law in the District of Columbia and is admitted to the Federal Claims Court Bar where the Vaccine Court sits. She is a member of the Vaccine Injured Petitioners Bar Association, a national bar representing the interests of claimants in the NVICP, where she served as President for four years. She is also a member of the U.S. Court of Federal Claims Bar Association and currently serves on its Board of Governors. She is a member of the American Association for Justice (formerly ATLA), and its Vaccine Group.
In addition to her private practice, Ms. Gentry is the Director of the Vaccine Injury Litigation Clinic at The George Washington University Law School where she supervises a team of student-attorneys, certified to practice in the US Court of Federal Claims, representing vaccine injured children and adults in the NVICP. Prof. Gentry supervises student-attorneys in all phases of vaccine injury litigation. The Vaccine Injury Litigation Clinic has obtained millions of dollars of compensation for clients in a wide variety of cases to ensure that children and adults with severe mental and physical disabilities resulting from vaccine injuries receive excellent care for the rest of their lives. The Clinic’s student-attorneys have also won important appellate victories, including rulings from the US Court of Appeals for the Federal Circuit making it easier for vaccine-injured persons to obtain compensation in court. She has practiced vaccine litigation since 2001.
Previously, she served as the Senior Analyst on the Defense and Aerospace Companies Briefing for Teal Group Corporation. Ms. Gentry consulted for the US Government, French Government, and major prime contractors on European defense industry consolidation, antitrust issues, specific defense market overviews for product development, and profiles of companies designed to assist management in acquisition activities. After leaving Teal Group, she worked as principal liaison to corporate clients, as well as the Washington National Opera and Domingo-Cafritz Young Artists Program advising them on a range of immigration issues.